Question 1

What are the potential benefits and risks of participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Clinical Trial Evaluating ITI-007 (Lumateperone) as a Monotherapy for the Treatment of Bipolar Depression clinical trial (NCT02600494). Contact the study team or your healthcare provider for specific answers.

Question 2

How does ITI-007 compare to my current treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Clinical Trial Evaluating ITI-007 (Lumateperone) as a Monotherapy for the Treatment of Bipolar Depression clinical trial (NCT02600494). Contact the study team or your healthcare provider for specific answers.

Question 3

What will the study visits involve and how often will I need to come in?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Clinical Trial Evaluating ITI-007 (Lumateperone) as a Monotherapy for the Treatment of Bipolar Depression clinical trial (NCT02600494). Contact the study team or your healthcare provider for specific answers.

Question 4

What should I do if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Clinical Trial Evaluating ITI-007 (Lumateperone) as a Monotherapy for the Treatment of Bipolar Depression clinical trial (NCT02600494). Contact the study team or your healthcare provider for specific answers.

Question 5

How long will the treatment last, and what happens after the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Clinical Trial Evaluating ITI-007 (Lumateperone) as a Monotherapy for the Treatment of Bipolar Depression clinical trial (NCT02600494). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any costs associated with participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Clinical Trial Evaluating ITI-007 (Lumateperone) as a Monotherapy for the Treatment of Bipolar Depression clinical trial (NCT02600494). Contact the study team or your healthcare provider for specific answers.

What this study is about